Introduction and background -- Clinical trials -- Treatment, financing, and costs -- Behavioral responses and consent.
0
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
New treatments for addiction.
9780309091282
National Institute on Drug Abuse
Immunotherapy.
Substance abuse-- Chemotherapy.
Substance abuse-- Treatment.
Clinical Trials as Topic.
Delayed-Action Preparations-- therapeutic use.
Health Care Costs.
Health Policy.
Immunotherapy-- ethics.
Immunotherapy-- legislation & jurisprudence.
Informed Consent.
Substance-Related Disorders-- psychology.
Substance-Related Disorders-- therapy.
Immunothérapie.
Polytoxicomanie-- Chimiothérapie.
Polytoxicomanie-- Traitement.
Drogenabhängigkeit
Ethik
HEALTH & FITNESS-- Diseases-- General.
Immunotherapy.
Immuntherapie
MEDICAL-- Clinical Medicine.
MEDICAL-- Diseases.
MEDICAL-- Evidence-Based Medicine.
MEDICAL-- Internal Medicine.
Pharmakologischer Antagonist
Rauschgift
Retardpräparat
Substance abuse-- Treatment.
United States.
2
HEA-- 039000
MED-- 014000
MED-- 022000
MED-- 045000
MED-- 112000
616
.
86/061
22
RC564
.
N488
2004eb
2004
H-678
WM
270
N5327
2004
Harwood, Henrick J.
Myers, Tracy G.
National Academies (U.S.)., Committee on Immunotherapies and Sustained-Release Formulations for Treating Drug Addiction.